Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug
Motolese, M.
Bollettino Chimico Farmaceutico 109(6): 363-368
1970
ISSN/ISBN: 0006-6648 PMID: 4394953 Document Number: 20888
Document emailed within 1 workday
Related Documents
Di Veroli, C.; Compagno, S. 1982: Clinical evaluation of a beta-blocking agent in a single daily dose La Clinica Terapeutica 101(6): 623-628Sanderson, I.M.; Kennerley, J.W.; Parr, G.D. 1984: An evaluation of the relative importance of formulation and process variables using factorial design Journal of Pharmacy and Pharmacology 36(12): 789-795
De Ambroggi, L.; Perotta, G.M.; Satolli, R.; Lotto, A. 1977: Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct Bollettino Della Societa Italiana di Cardiologia 22(8): 1343-1351
Palatsi, R. 1976: A skin reaction to pindololum, a beta-blocking drug Annals of Clinical Research 8(4): 239-240
Bauer, G.E.; Michell, G. 1970: Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug Medical Journal of Australia 1(4): 170-173
Moore, G.E.; O'Donnell, S.R. 1970: A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole Journal of Pharmacy and Pharmacology 22(3): 180-188
Chalmers, J.; Wing, L.; West, M.; Bune, A.; Johnston, C.; Jackson, B.; McGrath, B.; Mashford, M.L.; Heath, W.; Westwood, B. 1987: Felodipine compared to prazosin as additional therapy to a beta-blocking drug Journal of Cardiovascular Pharmacology 10(Suppl 10): S82-S84
Pyörälä, K.; Mattila, S.; Leirisalo, M.; Toivonen, S. 1976: The antihypertensive effect of a new beta-blocking drug timolol in combination with hydrochlorothiazide Duodecim; Laaketieteellinen Aikakauskirja 92(11): 588-596
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Jäättelä, A.; Pyöräiä, K. 1976: The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone Duodecim; Laaketieteellinen Aikakauskirja 92(11): 597-603
Cerasola, G.A.; Botta, R.M.; Riolo, A.; Amico, L.M. 1979: Efficacy of a new beta-blocking drug (atenolol, ICi 66082) in treating arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(5): 493-500
Pentel, P.R.; Salerno, D.M. 1990: Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents Medical Journal of Australia 152(2): 88-94
Nakahara, H.; Nakazawa, M.; Tsukada, T.; Imai, S. 1985: Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 277(2): 253-263
Leuenberger, H.; Becher, W. 1975: A factorial design for compatibility studies on preformulation work Pharmaceutica Acta Helvetiae 50(4): 88-91
Liebl, G. 1982: Balanced minimal diet in ambulatory patients Münchener Medizinische Wochenschrift 124(20): 507-508
Amerini, S.; Bini, R.; Cerbai, E.; Ledda, F.; Mantelli, L.; Mugelli, A. 1986: In vitro evaluation of the beta-blocking and electrophysiological properties of mepindolol Archives Internationales de Pharmacodynamie et de Therapie 282(2): 276-287
Salmini, G.; Cione, R.; Oldrini, R. 1970: Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative Minerva Cardioangiologica 18(5): 311-315
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Avachat, A.M.; Patel, K.B.; Rokade, M.S.; Dash, R.R. 2011: Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design PDA Journal of Pharmaceutical Science and Technology 65(1): 12-19